CHX Technologies has developed, patented, trialed and gained Canadian and European approvals for Prevora over 15 years, a period of development common to new drugs which are seeking a first-in-class therapeutic indication. CHX has also extensively researched and test marketed various marketing channels for Prevora. Recent announcements by CHX follow:
- November 2016: CHX Technologies Partners with Ei A Pharmaceutical Solutionworks™ on the Manufacture of Prevora for the Canadian & European Market and for the Submission of Prevora’s New Drug Application to the US FDA
- June 2016: CHX retains TPIreg as a strategic regulatory advisor in its preparation of Prevora's New Drug Application to the US Food & Drug Administration.
- April 2016: CHX & Canada's MCI Medical Clinics announce a strategic partnership to deliver better oral health via Prevora.
Click Links below for complete story.